Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPOS guideline versus GP free-choice treatment for acute rhinosinusitis
NL-OMON36879Withdrawn
- Sponsor
- Amsterdam University Medical Center
- Start
- Dec 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of mometasone and amoxicillin in acute rhinosinusitis (ARS) and nasopharyngitis (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Time to symptom resolution compatible with normal daily activities. Planned start Dec 2012; status: withdrawn.
02
Drugs
mometasoneamoxicillin
03
Conditions
acute rhinosinusitis (ARS)nasopharyngitis
Beyond the preview
Go deeper on NL-OMON36879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36879.